site logo
Last modified: 2017-03-19 12:45:34

First commercial nanotechnology diagnostic system based on our chemistry

The abioSCOPE by Swiss company ABIONIC. Based on a disruptive nanotechnology, Abionic is committed to improving the world of diagnostics through innovation by providing a rapid quantitative platform to medical practitioners.

Abionic recently launched its first test designed to deliver specific, quantitative and personalized information about patients’ allergen sensitization at the point-of-care. Discover more...

abionic logo
Go back